Harnessing nanobiotechnology for cerebral ischemic stroke management

Lu Tang1,2, Cong Fu1,2, Aining Zhang1,2

  • 1State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China. wangcpu209@cpu.edu.cn.

Biomaterials Science
|December 22, 2022
PubMed
Summary

Nanobiotechnology offers novel strategies for managing cerebral ischemic stroke by overcoming limitations of traditional treatments. Various nanoplatforms enable targeted delivery for neuroprotection, anti-inflammation, and other therapies.

Related Concept Videos